Asia FX muted, dollar weakens slightly ahead of Fed rate decision
Investing.com - Evotec SE ADR reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Evotec SE ADR announced earnings per share of $0.06 on revenue of $177.27M. Analysts polled by Investing.com EPS of $0.21 on revenue of $188.75M.
Evotec SE ADR 's are down 29.95% and is trading at $8.54 , still down 66.23% from its 52 week high of $25.29 set on Wednesday, December 15, 2021.
Evotec SE ADR follows other major Healthcare sector earnings this month
Evotec SE ADR's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar